Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells. by Malgorzata Borkowska (3166719)

“…<p>(<b>A</b>) Significant decreases in the proportions of PV+ cells were observed in fSSp, SSp, vAud and in Vis, but not MPFC. …”

PRL decreased the proapoptotic ratio Bax/Bcl-2 in hippocampal neurons exposed with Glu. by Nadia A. Rivero-Segura (4006709)

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

Decreases in locomotor responses to a single METH injection in <i>Ptprz</i>-KO mice. by Akihiro Fujikawa (122649)

Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

“…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”

Random forest analysis showing discriminating biomarkers of diet-challenge in their decreasing orders of mean decrease accuracies (MDA). by Biswapriya B. Misra (563793)

Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

Decrease of the mean number of natural teeth and POPs with age. by Sul-Hee Kim (11873853)

Kisspeptin-10 decreases blood flow in the peripheral vasculature. by Iain Sawyer (356468)

DOX decreases body mass gain over time in a sub-chronic toxicity model. by Gonçalo C. Pereira (156673)

Activation of Fas decreases poly I:C-induced IL-8, IL-10, TNFα and IFNβ expression. by Caitriona Lyons (717760)

Mean squared error of estimates decreases with larger datasets. by Alexander Eugene Zarebski (12078347)

“…<p>The mean squared error in the estimates of under the posterior distribution decreases as the size of the dataset increases. …”

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

Variable Importance Measures Estimated by Mean Decreased Accuracy. by N. Maritza Dowling (434265)

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Results for K_s/D  = 3.62 × 10⁻⁴, (a) Power, (b) Frequency, and (c) Amplitude. by Muhammad Hammad Bucha (21736111)

Subjects:

Results for K_s/D  = 1.51 × 10⁻⁴ (a) Power, (b) Frequency, and (c) Amplitude. by Muhammad Hammad Bucha (21736111)

Subjects:

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Mean ± SD values for the parameters found with fittings of Eq. 8, S1 Appendix) to the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and maximum hor... by Kai Roecker (847195)

Subjects: